TY - JOUR
T1 - Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
AU - Andres-Mateos, Eva
AU - Mejias, Rebeca
AU - Sasaki, Masayuki
AU - Li, Xiaojie
AU - Lin, Brian M.
AU - Biskup, Saskia
AU - Zhang, Li
AU - Banerjee, Rebecca
AU - Thomas, Bobby
AU - Yang, Lichuan
AU - Liu, Guosheng
AU - Beal, M. Flint
AU - Huso, David L.
AU - Dawson, Ted M.
AU - Dawson, Valina L.
PY - 2009/12/16
Y1 - 2009/12/16
N2 - Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common known cause of Parkinson's disease (PD). Whether loss of LRRK2 function accounts for neurodegeneration of dopamine neurons in PD is not known, nor is it known whether LRRK2 kinase activity modulates the susceptibility of dopamine (DA) neurons to the selective dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). To better understand the role of LRRK2 in DA neuronal survival and its role in the susceptibility of DA neurons to MPTP, we generated LRRK2 knock-out (KO) mice lacking the kinase domain of LRRK2. Here, we show that LRRK2 KO mice are viable and have no major abnormalities and live to adulthood. The dopaminergic system is normal in LRRK2 KO mice as assessed via HPLC for DA and its metabolites and via stereologic assessment of DA neuron number in young and aged mice. Importantly, there is no significant difference in the susceptibility of LRRK2 KO and wild-type mice to MPTP. These results suggest that LRRK2 plays little if any role in the development and survival of DA neurons under physiologic conditions. Thus, PD due to LRRK2 mutations are likely not due to a loss of function. Moreover, LRRK2 is not required for the susceptibility of DA neurons to MPTP.
AB - Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common known cause of Parkinson's disease (PD). Whether loss of LRRK2 function accounts for neurodegeneration of dopamine neurons in PD is not known, nor is it known whether LRRK2 kinase activity modulates the susceptibility of dopamine (DA) neurons to the selective dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). To better understand the role of LRRK2 in DA neuronal survival and its role in the susceptibility of DA neurons to MPTP, we generated LRRK2 knock-out (KO) mice lacking the kinase domain of LRRK2. Here, we show that LRRK2 KO mice are viable and have no major abnormalities and live to adulthood. The dopaminergic system is normal in LRRK2 KO mice as assessed via HPLC for DA and its metabolites and via stereologic assessment of DA neuron number in young and aged mice. Importantly, there is no significant difference in the susceptibility of LRRK2 KO and wild-type mice to MPTP. These results suggest that LRRK2 plays little if any role in the development and survival of DA neurons under physiologic conditions. Thus, PD due to LRRK2 mutations are likely not due to a loss of function. Moreover, LRRK2 is not required for the susceptibility of DA neurons to MPTP.
UR - http://www.scopus.com/inward/record.url?scp=72449198522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72449198522&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.4357-09.2009
DO - 10.1523/JNEUROSCI.4357-09.2009
M3 - Article
C2 - 20016100
AN - SCOPUS:72449198522
SN - 0270-6474
VL - 29
SP - 15846
EP - 15850
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 50
ER -